Paul van Damme

Paul van Damme

Director/Board Member bei XORTX THERAPEUTICS INC.

Vermögen: 26 307 $ am 31.03.2024

Health Technology
Commercial Services
Finance

Profil

Paul Joseph van Damme currently works at Ontario Genomics Institute, as Director, Wildlaw Capital Markets, Inc., as Managing Director, XORTX Therapeutics, Inc., as Independent Director from 2018, and WD Capital Markets, Inc., as Managing Director.
Mr. van Damme also formerly worked at Quest PharmaTech, Inc., as Independent Director from 2012 to 2015, ZipLocal, Inc., as Chief Financial Officer & Director from 2012 to 2016, Insception Biosciences, Inc., as Director, Structural Genomics Consortium, as Chief Financial Officer, Secretary & Director from 2012 to 2019, Ontario Genomics Institute (Private Equity), as Director, XORTX Pharma Corp., as Director, OncoQuest, Inc., as Director from 2015 to 2020, Aptose Biosciences, Inc., as Chief Financial Officer from 2004 to 2005, Vasogen, Inc., as CFO in 2007, Bradmer Pharmaceuticals, Inc., as Chief Financial Officer from 2007 to 2018, Allelix Biopharmaceuticals, Inc., as Chief Financial Officer, NXA, Inc., as Chief Financial Officer, Crosswinds Holdings, Inc., as Chief Financial Officer from 2013 to 2015, PricewaterhouseCoopers, Inc., as Principal, Laidlaw, Inc. (Connecticut), as Chief Financial Officer, Canada Systems Group Ltd., as Chief Financial Officer in 1991, Junior Achievement of Central Ontario, as Chief Financial Officer, Ellipsiz Communications Ltd., as Chief Financial Officer from 2011 to 2015, Galaxy Digital Holdings Ltd., as Chief Financial Officer, and Mind Medicine (MindMed), Inc., as Chief Financial Officer in 2020.
Mr. van Damme received his Masters Business Admin degree from Rotman School of Management and undergraduate degree from the University of Toronto.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
04.03.2024 7 110 ( 0,36% ) 26 307 $ 31.03.2024

Aktive Positionen von Paul van Damme

UnternehmenPositionBeginn
XORTX THERAPEUTICS INC. Director/Board Member 25.01.2018
Corporate Officer/Principal -
Ontario Genomics Institute Director/Board Member 20.10.2010
Corporate Officer/Principal -
Alle aktiven Positionen von Paul van Damme

Ehemalige bekannte Positionen von Paul van Damme

UnternehmenPositionEnde
MIND MEDICINE (MINDMED) INC. Director of Finance/CFO 01.04.2020
Director/Board Member 01.02.2020
Director of Finance/CFO 31.05.2019
GALAXY DIGITAL HOLDINGS LTD. Director of Finance/CFO 31.07.2018
Director of Finance/CFO 01.07.2018
Sehen Sie sich die Erfahrung von Paul van Damme im Detail an

Ausbildung von Paul van Damme

Rotman School of Management Masters Business Admin
University of Toronto Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Paul van Damme im Detail an

Beziehungen

58

Beziehungen ersten Grades

26

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
APTOSE BIOSCIENCES INC.

Health Technology

QUEST PHARMATECH INC.

Commercial Services

XORTX THERAPEUTICS INC.

Health Technology

GALAXY DIGITAL HOLDINGS LTD.

Commercial Services

MIND MEDICINE (MINDMED) INC.

Health Technology

Private Unternehmen19

Health Technology

Commercial Services

Allelix Biopharmaceuticals, Inc.

Health Technology

Non-Energy Minerals

Health Technology

Commercial Services

Finance

Commercial Services

Laidlaw, Inc. (Connecticut)

Transportation

Canada Systems Group Ltd.

Miscellaneous

Ontario Genomics Institute

Finance

Commercial Services

Finance

Health Technology

Health Technology

Communications

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Paul van Damme